American Century Companies Inc. raised its position in ZimVie Inc. (NASDAQ:ZIMV – Free Report) by 23.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 628,050 shares of the company’s stock after purchasing an additional 121,053 shares during the quarter. American Century Companies Inc. owned about 2.28% of ZimVie worth $8,761,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. SG Americas Securities LLC increased its stake in shares of ZimVie by 15.7% during the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock worth $155,000 after buying an additional 1,508 shares during the period. EMC Capital Management boosted its stake in shares of ZimVie by 47.0% in the fourth quarter. EMC Capital Management now owns 13,802 shares of the company’s stock valued at $193,000 after buying an additional 4,414 shares in the last quarter. Principal Financial Group Inc. purchased a new position in ZimVie in the 3rd quarter valued at approximately $275,000. Bailard Inc. grew its stake in ZimVie by 35.0% in the 4th quarter. Bailard Inc. now owns 21,194 shares of the company’s stock valued at $296,000 after acquiring an additional 5,494 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new position in shares of ZimVie during the 3rd quarter worth approximately $528,000. 95.63% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Needham & Company LLC reissued a “hold” rating on shares of ZimVie in a research report on Thursday, March 13th.
ZimVie Price Performance
ZIMV stock opened at $10.56 on Thursday. The firm has a market cap of $294.06 million, a P/E ratio of -0.81 and a beta of 2.10. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. ZimVie Inc. has a 1 year low of $10.41 and a 1 year high of $22.40. The stock has a 50-day simple moving average of $12.85 and a 200-day simple moving average of $13.92.
ZimVie (NASDAQ:ZIMV – Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.02. The firm had revenue of $111.52 million during the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. On average, equities analysts predict that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.
About ZimVie
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Stories
- Five stocks we like better than ZimVie
- Where to Find Earnings Call Transcripts
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The 3 Most Talked About Investments on WallStreetBets Right Now
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding ZIMV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ZimVie Inc. (NASDAQ:ZIMV – Free Report).
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.